Carcinoma, Hepatocellular

Showing NaN - NaN of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Hefei, Anhui, China
  • +22 more
Mar 26, 2014

Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)

Terminated
  • Carcinoma, Hepatocellular
  • Fountain Valley, California
  • +170 more
Dec 7, 2012